Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022.
Ozaki Y, Hara H, Onuma Y, Katagiri Y, Amano T, Kobayashi Y, Muramatsu T, Ishii H, Kozuma K, Tanaka N, Matsuo H, Uemura S, Kadota K, Hikichi Y, Tsujita K, Ako J, Nakagawa Y, Morino Y, Hamanaka I, Shiode N, Shite J, Honye J, Matsubara T, Kawai K, Igarashi Y, Okamura A, Ogawa T, Shibata Y, Tsuji T, Yajima J, Iwabuchi K, Komatsu N, Sugano T, Yamaki M, Yamada S, Hirase H, Miyashita Y, Yoshimachi F, Kobayashi M, Aoki J, Oda H, Katahira Y, Ueda K, Nishino M, Nakao K, Michishita I, Ueno T, Inohara T, Kohsaka S, Ismail TF, Serruys PW, Nakamura M, Yokoi H, Ikari Y; Task Force on Primary Percutaneous Coronary Intervention (PCI) of the Japanese Cardiovascular Interventional Therapeutics (CVIT). Ozaki Y, et al. Among authors: hirase h. Cardiovasc Interv Ther. 2022 Jan;37(1):1-34. doi: 10.1007/s12928-021-00829-9. Epub 2022 Jan 12. Cardiovasc Interv Ther. 2022. PMID: 35018605 Free PMC article. Review.
Impact of severe coronary disease associated or not associated with diabetes mellitus on outcome of interventional treatment using stents: results from HERZ (Heart Research Group of Kanazawa) analyses.
Uchiyama K, Ino H, Hayashi K, Fujioka K, Takabatake S, Yokawa J, Namura M, Mizuno S, Tatami R, Kanaya H, Nitta Y, Michishita I, Hirase H, Ueda K, Aoyama T, Okeie K, Haraki T, Mori K, Araki T, Minamoto M, Oiwake H, Konno T, Sakata K, Kawashiri M, Yamagishi M; Heart Research Group of Kanazawa. Uchiyama K, et al. Among authors: hirase h. J Int Med Res. 2011;39(2):549-57. doi: 10.1177/147323001103900224. J Int Med Res. 2011. PMID: 21672360 Free article.
A patient with significant slow-flow phenomenon during percutaneous coronary intervention for ST elevation myocardial infarction associated with scattered necrotic core by virtual histology intravascular ultrasound.
Haraki T, Hirase H, Ohta M, Uno Y, Sakata K, Kawashiri MA, Yamagishi M. Haraki T, et al. Among authors: hirase h. Cardiovasc Interv Ther. 2011 Sep;26(3):290-5. doi: 10.1007/s12928-011-0073-0. Epub 2011 Jul 7. Cardiovasc Interv Ther. 2011. PMID: 24122600
Impact of lesion morphology and associated procedures for left main coronary stenting on angiographic outcome after intervention: sub-analysis of Heart Research Group of Kanazawa, HERZ, Study.
Kawashiri MA, Sakata K, Uchiyama K, Konno T, Namura M, Mizuno S, Tatami R, Kanaya H, Nitta Y, Michishita I, Hirase H, Ueda K, Aoyama T, Okeie K, Haraki T, Mori K, Araki T, Minamoto M, Oiwake H, Ino H, Hayashi K, Yamagishi M. Kawashiri MA, et al. Among authors: hirase h. Cardiovasc Interv Ther. 2014 Apr;29(2):117-22. doi: 10.1007/s12928-013-0222-8. Epub 2013 Nov 8. Cardiovasc Interv Ther. 2014. PMID: 24203580
Impact of combined lipid lowering and blood pressure control on coronary plaque: myocardial ischemia treated by percutaneous coronary intervention and plaque regression by lipid lowering and blood pressure controlling assessed by intravascular ultrasonography (MILLION) study.
Kawashiri MA, Sakata K, Hayashi K, Gamou T, Kanaya H, Miwa K, Ueda K, Higashikata T, Mizuno S, Michishita I, Namura M, Nitta Y, Katsuda S, Okeie K, Hirase H, Tada H, Uchiyama K, Konno T, Ino H, Nagase K, Yamagishi M; Behalf of the MILLION Study Group. Kawashiri MA, et al. Among authors: hirase h. Heart Vessels. 2017 May;32(5):539-548. doi: 10.1007/s00380-016-0910-2. Epub 2016 Oct 31. Heart Vessels. 2017. PMID: 27798731 Clinical Trial.
Impact of combined lipid lowering with blood pressure control on coronary plaque regression: rationale and design of MILLION study.
Kawashiri MA, Sakata K, Gamou T, Kanaya H, Miwa K, Ueda K, Higashikata T, Mizuno S, Michishita I, Namura M, Nitta Y, Katsuda S, Okeie K, Hirase H, Tada H, Uchiyama K, Konno T, Hayashi K, Ino H, Nagase K, Terashima M, Yamagishi M. Kawashiri MA, et al. Among authors: hirase h. Heart Vessels. 2015 Sep;30(5):580-6. doi: 10.1007/s00380-014-0522-7. Epub 2014 Jun 4. Heart Vessels. 2015. PMID: 24895097 Clinical Trial.
Characterization of baseline clinical factors associated with incident worsening kidney function in patients with non-valvular atrial fibrillation: the Hokuriku-Plus AF Registry.
Hayashi K, Tanaka Y, Tsuda T, Nomura A, Fujino N, Furusho H, Sakai N, Iwata Y, Usui S, Sakata K, Kato T, Tada H, Kusayama T, Usuda K, Kawashiri MA, Passman RS, Wada T, Yamagishi M, Takamura M; Hokuriku-Plus AF Registry Investigators. Hayashi K, et al. Heart Vessels. 2023 Mar;38(3):402-411. doi: 10.1007/s00380-022-02178-w. Epub 2022 Oct 17. Heart Vessels. 2023. PMID: 36251049
Correction: Characterization of baseline clinical factors associated with incident worsening kidney function in patients with non-valvular atrial fibrillation: the Hokuriku-Plus AF Registry.
Hayashi K, Tanaka Y, Tsuda T, Nomura A, Fujino N, Furusho H, Sakai N, Iwata Y, Usui S, Sakata K, Kato T, Tada H, Kusayama T, Usuda K, Kawashiri MA, Passman RS, Wada T, Yamagishi M, Takamura M; Hokuriku-Plus AF Registry Investigators. Hayashi K, et al. Heart Vessels. 2023 Mar;38(3):412. doi: 10.1007/s00380-022-02218-5. Heart Vessels. 2023. PMID: 36508013 No abstract available.
124 results